Skip to main content

Table 4 Summary of studies regarding application of the Oxford classification to patients with Henoch-Schönlein purpura nephritis

From: MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schönlein purpura nephritis

Study

No. of patients

Age

Definition of renal outcome

Significant pathologic parameters

Univariate model

Multivariate model

Child patients

 Çakıcı et el. (2019) [17]

75

< 18 years

< 90 mL/min/1.73 m2 or 50% decrease of eGFR; or persistent PU/HU

S1, T1/T2

T1/T2b

 Xu et el. (2018) [18]

104

< 18 years

< 90 mL/min/1.73 m2 or 50% decrease of eGFR

S1

Nonec

 The present study

113

< 18 years

ESRD or doubling of sCr

M1, T1/T2

M1, T1/T2

Adult patients

 Inagaki et el. (2018) [16]

74

≥18 years

ESRD or 30% decrease of eGFR

E1

E1d

 Kim et el. (2014)a [19]

61

≥16 years

ESRD; or < 60 mL/min/1.73 m2 or ≥ 30% decrease of eGFR

E1, T1/T2, Ca

E1, T1/T2e

 The present study

100

≥18 years

ESRD or doubling of sCr

T1/T2

T1/T2

  1. ESRD end-stage renal disease, sCr serum creatinine, eGFR estimated glomerular filtration rate, PU proteinuria, HU hematuria
  2. aCrescent formation was defined when crescents were ≥ 50% of the glomeruli, which differs from the updated Oxford classification (C1: 0–25%; C2: ≥25%)
  3. bAdjusted for E, S, T, and estimated glomerular filtration rate
  4. cAdjusted for M, E, S, T, and C
  5. dAdjusted for E, T, C, age, sex, and proteinuria
  6. eAdjusted for E, T, C, hypertension, proteinuria, and estimated glomerular filtration rate